Moll Wendén advised OXE Marine AB on the offering. OXE Marine AB will receive SEK 30.2 million of which SEK 1 million of the share issue is...
You must be a Standard 1 Year member to access this content.
Moll Wenden advised SensoDetect Aktiebolag on the deal. SensoDetect Aktiebolag completed a rights issuance of units amounting to approximately SEK 19.4 million with preferential rights to...
You must be a Standard 1 Year member to access this content.
Moll Wenden advised Scandinavian ChemoTech AB on the deal. Scandinavian ChemoTech AB completed the issuance of shares amounting to approximately SEK 14.85 million. ChemoTech is a Swedish medical...
You must be a Standard 1 Year member to access this content.
Moll Wendén advised OptiCept Technologies AB on the deal. OptiCept Technologies AB completed the issuance of shares and warrants of initially approximately SEK 26.1 million. Through the...
You must be a Standard 1 Year member to access this content.
Moll Wendén advised OptiCept Technologies AB on the deal. OptiCept Technologies AB announced an issue of units amounting to approximately SEK110 million with preferential rights for...
You must be a Standard 1 Year member to access this content.
Moll Wendén advised Calmark Sweden AB on the deal. Calmark Sweden AB completed an issue of units amounting to approximately SEK 26.1 million with preferential rights...
You must be a Standard 1 Year member to access this content.
Moll Wendén advised AegirBio AB on the deal. AegirBio AB is implementing a preferential rights issue of units to existing shareholders. If the rights issue is...
You must be a Standard 1 Year member to access this content.
Moll Wendén advised Twiik AB on the deal. Twiik AB is implementing a preferential rights issue of units to existing shareholders. If the rights issue is...
You must be a Standard 1 Year member to access this content.
